Govt. descended Price of 126 drugs by 40%

New Delhi
Government has fixed the ceiling price of 530 essential medicines that has resulted in price reduction of over 40 per cent in case of 126 drugs, Parliament. “National Pharmaceutical Pricing Authority has fixed the ceiling price of 530 medicines”, out of 680 NLEM medicines (628 net medicines) that are under the scheduled category of DPCO 2013. Out of 530 drugs, above 40 per cent price reduction has happened in case of 126 medicines, while prices of 34 drugs has come down in the range of 35-40 per cent. The drug pricing regulator has reduced the price of 26 medicines by 30-35 per cent while prices of 49 drugs have been reduced in the range of 25-30 per cent. While the prices of 65 medicines have been reduced in the range of 20-25 per cent, 43 medicines have witnessed the price reduction in the range of 15 to 20 per cent. Moreover, 57 drugs saw price reduction of 10-15 per cent, price of 50 drugs were reduced in range of 5-10 per cent. In case of 80 medicines the reduction with respect to maximum price was between 0 to 5 per cent. NPPA mandate is to fix or revise the prices of controlled bulk drugs and formulations and to enforce prices and availability of the medicines in the country. It also monitors prices of decontrolled drugs in order to keep them at reasonable levels.

  • Related Posts

    NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

    The officials identified the substance as Alprazolam manufactured illegally at the lab. HYDERABAD: In one of the largest such seizures in recent times, the Narcotics Control Bureau (NCB), Hyderabad, raided…

    Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha

    New Delhi: The Ministry of AYUSH has detailed its regulatory framework and ongoing initiatives to monitor heavy metal content in traditional medicines, responding to parliamentary concerns over quality and safety…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Commissioner FDA reviews enforcement measures

    Commissioner FDA reviews enforcement measures

    Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

    Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

    Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

    Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

    CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

    CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

    Piramal Pharma Gets 3 USFDA Observations at US Facility

    Piramal Pharma Gets 3 USFDA Observations at US Facility

    Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

    Eli Lilly pauses Indian obesity awareness campaign after regulatory notices